Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Suppr

超能文献

作者信息

Gilman J T, Gal P

机构信息

Clinical Pharmacology Service, Miami Children's Hospital, Florida.

出版信息

Clin Pharmacokinet. 1992 Jul;23(1):1-9. doi: 10.2165/00003088-199223010-00001.

DOI:10.2165/00003088-199223010-00001

PMID:1617855

Abstract

摘要

相似文献

Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Clin Pharmacokinet. 1992 Jul;23(1):1-9. doi: 10.2165/00003088-199223010-00001.

[Pediatric particularities of pharmacology].[药理学的儿科特殊性]

Rev Prat. 1990 May 1;40(13):1224-6.

Paediatric labelling requirements. Implications for pharmacokinetic studies.儿科标签要求。对药代动力学研究的影响。

Clin Pharmacokinet. 1994 Apr;26(4):308-25. doi: 10.2165/00003088-199426040-00006.

Pediatric pharmacology update. Essential concepts for prescribing.

Adv Nurse Pract. 2004 Jun;12(6):22-7; quiz 27-8.

Pharmacokinetics in children: history, considerations, and applications.儿童药代动力学：历史、考量因素及应用

J Am Acad Nurse Pract. 2000 Jun;12(6):236-9. doi: 10.1111/j.1745-7599.2000.tb00188.x.

Advances in pediatric pharmacology and toxicology.儿科药理学与毒理学进展

Adv Pediatr. 1995;42:593-629.

Advances in pediatric pharmacology and toxicology.儿科药理学与毒理学进展

Adv Pediatr. 1997;44:545-74.

Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.儿科患者的药代动力学研究。临床与伦理考量。

Clin Pharmacokinet. 1992 Jul;23(1):10-29. doi: 10.2165/00003088-199223010-00002.

Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.新生儿及儿童年龄组的治疗药物监测。问题及临床药代动力学影响。

Clin Pharmacokinet. 1990 Jul;19(1):1-10. doi: 10.2165/00003088-199019010-00001.

[Pediatric pharmacology: is treatment of children preceded by an adequate investigation?].[儿科药理学：对儿童的治疗是否先进行了充分的调查？]

An Esp Pediatr. 1989 May;30(5):359-62.

引用本文的文献

Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies.儿科风湿病学未能达到当前标准，呼吁利用数字健康技术实现儿童青少年特发性关节炎患者的健康公平。

Curr Rheumatol Rep. 2024 Jun;26(6):214-221. doi: 10.1007/s11926-024-01145-w. Epub 2024 Mar 11.

Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease.依托咪酯在患有先天性心脏病的新生儿和婴儿中的群体药代动力学。

Biopharm Drug Dispos. 2015 Mar;36(2):104-14. doi: 10.1002/bdd.1924. Epub 2015 Jan 21.

Limited capacity in US pediatric drug trials: qualitative analysis of expert interviews.美国儿科药物试验能力有限：专家访谈的定性分析。

Paediatr Drugs. 2011 Apr 1;13(2):119-24. doi: 10.2165/11584240-000000000-00000.

Safety and transparency of pediatric drug trials.儿科药物试验的安全性与透明度。

Arch Pediatr Adolesc Med. 2009 Dec;163(12):1080-6. doi: 10.1001/archpediatrics.2009.229.

Safety monitoring of drugs receiving pediatric marketing exclusivity.获得儿科市场独占权药物的安全性监测

Pediatrics. 2008 Sep;122(3):e628-33. doi: 10.1542/peds.2008-0585.

Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.巴西福塔莱萨住院儿童的标签外用药和未获许可药物的使用情况。

Eur J Clin Pharmacol. 2008 Nov;64(11):1111-8. doi: 10.1007/s00228-008-0543-1. Epub 2008 Aug 7.

Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.制造商产品说明书中儿科药物安全性的记录：对《加拿大药品和特殊产品汇编》的横断面评估

Paediatr Drugs. 2008;10(3):193-7. doi: 10.2165/00148581-200810030-00007.

Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.乙胺嘧啶和磺胺多辛在接受先天性弓形虫病治疗儿童中的群体药代动力学。

Antimicrob Agents Chemother. 2004 Oct;48(10):3794-800. doi: 10.1128/AAC.48.10.3794-3800.2004.

Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.阿贝卡星、万古霉素和帕尼培南在新生儿中的群体药代动力学。

Antimicrob Agents Chemother. 2004 Apr;48(4):1159-67. doi: 10.1128/AAC.48.4.1159-1167.2004.

Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring.丙戊酸盐的经皮反向离子电渗疗法：一种用于治疗药物监测的非侵入性方法。

Pharm Res. 2003 Sep;20(9):1508-13. doi: 10.1023/a:1025730815971.

本文引用的文献

Two-compartment gentamicin pharmacokinetics in premature neonates: a comparison to adults with decreased glomerular filtration rates.

J Pediatr. 1980 Feb;96(2):325-30. doi: 10.1016/s0022-3476(80)80840-7.

Optimized blood sampling protocols and sequential design of kinetic experiments.

Am J Physiol. 1981 May;240(5):R259-65. doi: 10.1152/ajpregu.1981.240.5.R259.

Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution.

Neurology. 1981 Sep;31(9):1107-12. doi: 10.1212/wnl.31.9.1107.

Learning ability and methylphenidate (Ritalin) plasma concentration in hyperkinetic children. A preliminary investigation.多动症儿童的学习能力与哌甲酯（利他林）血药浓度：一项初步调查

J Am Acad Child Psychiatry. 1982 Jan;21(1):27-30. doi: 10.1097/00004583-198201000-00006.

Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate.

Pediatrics. 1982 Jun;69(6):688-94.

Pharmacokinetics of tobramycin in cystic fibrosis.

J Pediatr. 1982 Feb;100(2):318-21. doi: 10.1016/s0022-3476(82)80664-1.

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.

J Pediatr. 1982 Feb;100(2):312-8. doi: 10.1016/s0022-3476(82)80663-x.

Distribution of phenobarbital in serum, brain and other organs from pediatric patients.苯巴比妥在儿科患者血清、脑及其他器官中的分布。

Dev Pharmacol Ther. 1984;7(3):153-9. doi: 10.1159/000457158.

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.氨基糖苷类血浆水平与革兰氏阴性菌血症患者死亡率的关联。

J Infect Dis. 1984 Mar;149(3):443-8. doi: 10.1093/infdis/149.3.443.

Clinical correlates of methylphenidate blood levels.

Ther Drug Monit. 1984;6(4):379-92. doi: 10.1097/00007691-198412000-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验